Trust Co. of Vermont Buys New MRK Holdings Worth $13.677 Million

Trust Co. of Vermont has acquired a new position in shares of Merck & Co., Inc. (NYSE:MRK), according to its recent Form 13F filing with the Securities and Exchange Commission.

The institutional investor purchased 106,435 shares of the company's stock, valued at approximately $13,677,000.

This is not an isolated instance, as other hedge funds have also recently bought and sold shares of Merck & Co., Inc.

Merck & Co., Inc. has been experiencing a surge in its stock price due to positive top-line INTerpath-001 results, which strengthened expectations that the vaccine could extend KEYTRUDA's growth runway and create a new oncology franchise.